Impact of Graphene oxide (GO) and reduced Graphene Oxide (rGO) on the TiO2 thin film composite (TiO2: GO/ rGO) photoanodes

Joshi, A. Sakshi; Elamurugu, Elangovan; Leela.S,

doi:10.1016/j.chphi.2024.100667

Chemical Physics Impact

2024

DOI: 10.1016/j.chphi.2024.100667

|View full text |Cite

Impact of Graphene oxide (GO) and reduced Graphene Oxide (rGO) on the TiO2 thin film composite (TiO2: GO/ rGO) photoanodes

A. Sakshi Joshi,

Elangovan Elamurugu,

Leela.S

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Graphene-Oxide Peptide-Containing Materials for Biomedical Applications

Gostaviceanu,

Gavrilaş,

Copolovici

et al. 2024

IJMS

View full text Add to dashboard Cite

This review explores the application of graphene-based materials (GBMs) in biomedicine, focusing on graphene oxide (GO) and its interactions with peptides and proteins. GO, a versatile nanomaterial with oxygen-containing functional groups, holds significant potential for biomedical applications but faces challenges related to toxicity and environmental impact. Peptides and proteins can be functionalized on GO surfaces through various methods, including non-covalent interactions such as π–π stacking, electrostatic forces, hydrophobic interactions, hydrogen bonding, and van der Waals forces, as well as covalent bonding through reactions involving amide bond formation, esterification, thiol chemistry, and click chemistry. These approaches enhance GO’s functionality in several key areas: biosensing for sensitive biomarker detection, theranostic imaging that integrates diagnostics and therapy for real-time treatment monitoring, and targeted cancer therapy where GO can deliver drugs directly to tumor sites while being tracked by imaging techniques like MRI and photoacoustic imaging. Additionally, GO-based scaffolds are advancing tissue engineering and aiding tissues’ bone, muscle, and nerve tissue regeneration, while their antimicrobial properties are improving infection-resistant medical devices. Despite its potential, addressing challenges related to stability and scalability is essential to fully harness the benefits of GBMs in healthcare.

show abstract

Graphene-Oxide Peptide-Containing Materials for Biomedical Applications

Gostaviceanu,

Gavrilaş,

Copolovici

et al. 2024

IJMS

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Impact of Graphene oxide (GO) and reduced Graphene Oxide (rGO) on the TiO2 thin film composite (TiO2: GO/ rGO) photoanodes

Cited by 1 publication

References 28 publications

Graphene-Oxide Peptide-Containing Materials for Biomedical Applications

Graphene-Oxide Peptide-Containing Materials for Biomedical Applications

Contact Info

Product

Resources

About